Our Health Economics and Methodology team is heading to ISPOR Europe 2026. We’re presenting four posters on early evidence for new health technologies. Early evidence helps innovators and the NHS see the likely value of a new treatment or tool, long before big decisions get made. Our posters show how we do this across stroke, […]
Strong clinical evidence rarely wins funding on its own. NHS decision-makers need to see what your innovation costs, what it saves and what it changes. That case has to be credible. It also has to arrive early enough to shape your development, rather than late enough to only describe it. This session shows you how […]
NHS organisations need to know they can put your innovation into practice. Is it affordable? Will it scale? Will it deliver in a busy service, not just in a study? This session covers the evidence that answers those questions, and how to fund the work that produces it. Who should attend Early- and mid-stage health […]